Postoperative Radiotherapy for Non-Small Cell Carcinoma

  • Ellen Kim
  • Mitchell Machtay
Part of the Medical Radiology book series (MEDRAD)


The role of post-operative radiotherapy (PORT) in treatment of non-small cell lung cancer (NSCLC) is unclear. Currently, the available evidence suggests that PORT is indicated for stage II and III (node-positive) NSCLC, but not for stage I NSCLC. However, it is still disputed in which cases patterns of failure necessitate further treatment following surgery, and if it is warranted, the question becomes whether to do radiotherapy instead of or with (before, during, or after) chemotherapy. Study of PORT is further complicated by the improvement of radiotherapy techniques in recent decades, and the shortage of well-defined prospective randomized trials since their implementation. Advances in technology have allowed more precise administration of higher doses of radiation with lower exposure of healthy tissues, resulting in greater local control and lower treatment-related toxicities. Weighing the benefits and risks to determine the overall usefulness of PORT is difficult and will require future studies.


Adjuvant Chemotherapy Locoregional Control Bronchial Stump Port Group IIIA NSCLC 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Arriagada R, Bergman B, Dunant A et al (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350(4):351–360. PMID: 14736927Google Scholar
  2. Bradley JD, Paulus R, Graham MV et al (2005) Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group–RTOG 9705. J Clin Oncol 23(15):3480–3487. PMID: 15908657Google Scholar
  3. Burdett S, Stewart L, PORT Meta-analysis Group (2005) Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis. Lung Cancer 47(1):81–83. PMID: 15603857Google Scholar
  4. Dai H, Hui Z, Ji W (2011) Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution. Oncologist 16(5):641–650. Epub 2011 Apr 11, PMID: 21482587Google Scholar
  5. Dautzenberg B, Chastang C, Arriagada R et al (1995) Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d’Etude et de Traitement des Cancers Bronchiques). Cancer 76(5):779–786, PMID: 8625180Google Scholar
  6. Dautzenberg B, Arriagada R, Chammard AB et al (1999) A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d’Etude et de Traitement des Cancers Bronchiques. Cancer 86(2):265–273. PMID: 10421262Google Scholar
  7. Debevec M, Bitenc M, Vidmar S et al (1996) Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer: randomized clinical study 1988–1992. Lung Cancer 14(1):99–107. PMID: 8696724Google Scholar
  8. Decker RH, Wilson LD (2008) Postoperative radiation therapy for non-small cell lung cancer. Semin Thorac Cardiovasc Surg 20(3):184–187. PMID: 19038726Google Scholar
  9. Douillard JY, Rosell R, De Lena M et al (2008) Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys 72(3):695–701. Epub 2008 Apr 24.18439766Google Scholar
  10. Feng QF, Wang M, Wang LJ et al (2000) A study of postoperative radiotherapy in patients with non-small-cell lung cancer: a randomized trial. Int J Radiat Oncol Biol Phys. 47(4):925–929. PMID: 10863061Google Scholar
  11. Keller SM, Adak S, Wagner H et al (2000) A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 343(17):1217–1222. PMID: 11071672Google Scholar
  12. Kelsey CR, Light KL, Marks LB (2006) Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes. Int J Radiat Oncol Biol Phys 65(4):1097–1105. Epub 2006 May 6, PMID: 16682136Google Scholar
  13. Kelsey CR, Marks LB, Wilson LD (2008) Postoperative radiation therapy for lung cancer: where do we stand? Oncology (Williston Park) 22(3):301–310; discussion 310, 314–315, 319. PMID: 18494356Google Scholar
  14. Lafitte JJ, Ribet ME, Prevost BM et al (1996) Postresection irradiation for T2N0M0 non-small cell carcinoma: a prospective randomized trial. Ann Thorac Surg 62(3):830–834. PMID: 8784014Google Scholar
  15. Lally BE, Detterbeck FC, Geiger AM et al (2007) The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the surveillance, epidemiology, and end results database. Cancer 110(4):911–917. PMID: 17620279Google Scholar
  16. Le Pechoux C (2011) Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. Oncologist 16(5):672–681. Epub 2011 Mar 4, PMID: 21378080Google Scholar
  17. Machtay M (2008) PORTable indications in non-small-cell lung carcinoma. Oncology 22:301–310Google Scholar
  18. Machtay M, Lee JH, Shrager JB et al (2001) Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J Clin Oncol 19(19):3912–3917. PMID: 11579111Google Scholar
  19. Masson-Cote L, Couture C, Fortin A et al (2011) Postoperative radiotherapy for lung cancer: improvement in locoregional control using three-dimensional compared with two-dimensional technique. Int J Radiat Oncol Biol Phys 80(3):686–691Google Scholar
  20. Matsugama H, Nakahara R, Ishikawa Y et al (2008) Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved. Interact Cardiovasc Thorac Surg 7(4):573–577. Epub 2008 Apr 15, PMID: 18413349Google Scholar
  21. Mayer R, Smolle-Juettner FM, Szolar D et al (1997) Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest 112(4):954–959. PMID: 9377958Google Scholar
  22. Miles EF, Kelsey CR, Kirkpatrick JP et al (2007) Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: calculations from clinical trials. Int J Radiat Oncol Biol Phys 68(4):1047–1052. Epub 2007 May 15, PMID: 7507176Google Scholar
  23. Moretti L, Yu DS, Chen H et al (2009) Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy. Oncologist 14(11):1106–1115. Epub 2009 Nov 6, PMID: 19897534Google Scholar
  24. NSCLC Meta-analyses Collaborative Group, Arriagada R, Auperin A et al (2010) Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 375(9722):1267–1277. Epub 2010 Mar 24, PMID: 20338627Google Scholar
  25. Phlips P, Rocmans P, Vanderhoeft P et al (1993) Postoperative radiotherapy after pneumonectomy: impact of modern treatment facilities. Int J Radiat Oncol Biol Phys 27(3):525–529. PMID: 8226144Google Scholar
  26. PORT Meta-analysis Trialists Group (1998) Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet. 352(9124):257–263. PMID: 9690404Google Scholar
  27. Sawyer TE, Bonner JA, Gould PM et al (1997) The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement. Cancer 80(8):1399–1408. PMID: 9338463Google Scholar
  28. Saynak M, Higginson DS, Morris DE et al (2010) Current status of postoperative radiation for non-small-cell lung cancer. Semin Radiat Oncol 20(3):192–200. PMID: 20685582Google Scholar
  29. Scotti V, Meattini I, Saieva C et al (2010) Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients. Radiother Oncol 96(1):84–88. Epub 2010 Jun 11, PMID: 20541823Google Scholar
  30. Stephens RJ, Girling DJ, Bleehen NM (1996) The role of postoperativef radiotherapy in non-smalol cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2N1-2M0 disease. Medical research council lung cancer working party. Br J Cancer 74(4):632–639. PMID: 8761382Google Scholar
  31. Strauss GM, Herndon JE II, Maddaus MA et al (2008) Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 26(31):5043–5051. Epub 2008 Sept 22, PMID: 18809614Google Scholar
  32. Taylor NA, Liao ZX, Stevens C et al (2003) Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery. Int J Radiat Oncol Biol Phys 56(3):616–625. PMID: 12788166Google Scholar
  33. Trodella L, Granone P, Valente S et al (2002) Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol 62(1):11–19. PMID: 11830308Google Scholar
  34. Van Houtte P, Rocmans P, Smets P et al (1980) Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 6(8):983–986. PMID: 6998936Google Scholar
  35. Varlotto JM, Medford-Davis LN, Recht A (2010) Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer. Cancer 116(10):2390–2400. PMID: 20225332Google Scholar
  36. Wakelle HA, Stephenson P, Keller SM et al (2005) Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590. Lung Cancer 48(3):389–397. Epub 2005 Jan 5, PMID: 15893008Google Scholar
  37. Weisenburger TH (1994) Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. LCSG 773. Chest 106(6 Suppl):297S–301S. PMID: 7988248Google Scholar
  38. Winton T, Livingston R, Johnston D et al (2005) Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352(25):2589–2597. PMID: 15972865Google Scholar
  39. Zou B, Xu Y, Li T et al (2010) A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease. Int J Radiat Oncol Biol Phys 77(2):321–328. Epub 2009 Sept 21, PMID: 19775829Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg  2011

Authors and Affiliations

  1. 1.Department of Radiation OncologyCase Western Reserve UniversityClevelandUSA
  2. 2.Case Western Reserve University School of MedicineClevelandUSA

Personalised recommendations